Cite
HARVARD Citation
Lue, J. et al. (n.d.). DUAL INHIBITION OF EZH2 AND HDAC IS SYNERGISTIC IN EZH2 DYSREGULATED LYMPHOMAS. Hematological oncology. pp. 254-255. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Lue, J. et al. (n.d.). DUAL INHIBITION OF EZH2 AND HDAC IS SYNERGISTIC IN EZH2 DYSREGULATED LYMPHOMAS. Hematological oncology. pp. 254-255. [Online].